Search Results - "Tan, D C L"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Risk of hepatitis B reactivation and the role of novel agents and stem-cell transplantation in multiple myeloma patients with hepatitis B virus (HBV) infection by Mya, D.H.T., Han, S.T., Linn, Y.C., Hwang, W.Y.K., Goh, Y.T., Tan, D.C.L.

    Published in Annals of oncology (01-02-2012)
    “…The purpose of the study is to analyse the prevalence of hepatitis B virus (HBV) infection and its incidence of reactivation among multiple myeloma (MM)…”
    Get full text
    Journal Article
  2. 2

    Characterization of hemopoietic engraftment kinetics and development of secondary cytopenia in AML post auto-SCT and its correlation with survival outcome by Babatunde, A S, Tan, D C L, Heng, K K, Lee, J J, Loh, Y S M, Hwang, W Y K, Koh, M B C, Goh, Y T, Linn, Y C

    Published in Bone marrow transplantation (Basingstoke) (01-08-2009)
    “…We performed a single center retrospective analysis of 84 autologous hemopoietic stem cell transplants done for AML to characterize the pattern of hemopoietic…”
    Get full text
    Journal Article
  3. 3

    Treatment and outcome of acquired haemophilia A with a standard conventional regimen in a cohort without associated conditions by NG, H. J., TAN, D. C. L., LEE, L. H.

    “…Acquired haemophilia A (AH) is a rare bleeding disorder with significant risk of mortality. We conducted a study on the treatment and outcomes of patients with…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Fludarabine in Comparison to Alkylator-based Regimen as Induction Therapy for Chronic Lymphocytic Leukemia: A Systematic Review and Meta-analysis by Zhu, Q, Tan, DCL, Samuel, M, Chan, ESY, Linn, YC

    Published in Leukemia & lymphoma (01-11-2004)
    “…The superiority of Fludarabine over conventional therapy as primary induction therapy for patients with chronic lymphocytic leukemia (CLL) has been shown in…”
    Get full text
    Journal Article
  6. 6